1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Age and diagnostic performance of Alzheimer disease CSF biomarkers
(
- Contribution to journal › Article
- 2011
-
Mark
Regional Differences in Effects of APOE epsilon 4 on Cognitive Impairment in Non-Demented Subjects
(
- Contribution to journal › Article
- 2009
-
Mark
White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study
(
- Contribution to journal › Article
- 2008
-
Mark
A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome
(
- Contribution to journal › Article
-
Mark
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease
(
- Contribution to journal › Article
- 2006
-
Mark
Long-range PCR facilitates the identification of PMS2-specific mutations
(
- Contribution to journal › Article
- 2005
-
Mark
Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease
(
- Contribution to journal › Article
- 2003
-
Mark
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
(
- Contribution to journal › Article
-
Mark
Increased frequency of a new polymorphism in the cycle 2 (cdc2) gene in patients with Alzheimer's disease frontotemporal dementia
(
- Contribution to journal › Article